Clinical Trial Update: The Paclitaxel-Eluting Percutaneous Transluminal Coronary Angioplasty (PTCA) - Balloon Catheter in Coronary Artery Disease to Treat Chronic Total Occlusions [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a paclitaxel-eluting PTCA balloon catheter for treating chronic total occlusions in coronary artery disease has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Total Occlusion

Drugs mentioned

• Paclitaxel-eluting PTCA-balloon catheter (paclitaxel-eluting balloon catheter)

Snippet

Sponsor: University of Ulm | Conditions: Coronary Artery Disease, Chronic Total Occlusion | Phase 2 | Status: COMPLETED